Navigation
Elmer Video
Clininal Study Reporting Guidelines
| • | Randomized trials (CONSORT) |
| • | Observational studies (STROBE) |
| • | Systematic reviews (PRISMA) |
| • | Case reports (CARE) |
| • | Qualitative research (SRQR) |
| • | Diagnostic / prognostic studies (STARD) |
| • | Quality improvement studies (SQUIRE) |
| • | Economic evaluations (CHEERS) |
| • | Animal pre-clinical studies (ARRIVE) |
| • | Study protocols (SPIRIT) |
| • | Clinical practice guidelines (AGREE) |
Publishing Policy
Elmer Press Publishing Policies, and Guidelines to follow, click for details......
Advertising
Our journals are open access, which means all the contents of the journals are accessible freely to all viewers from every part of the world as long as they have internet accessibility, More...
Contact Us
Elmer Press Inc.
9225 Leslie Street, Suite 201
Richmond Hill
Ontario, L4B 3H6
Canada
Tel: 647-671-2629
elmerpublisher@hotmail.com (alternative email)
Search
Journals in Web of Science-ESCI
Emerging Sources Citation Index (ESCI) is an index in the Web of Science™ Core Collection
• Gastroenterology Research
• Cardiology Research
• J of Endocrinol. & Metabolism
• World Journal of Oncology
• Journal of Hematology
The above journals will have JCR Impact Factors in June 2023
Journals Permanent Archiving
All journals published by Elmer Press are archived in Portico, which provides permanent digital archiving for scholarly journals.
Follow Us
Publishing News
• Feb 28, 2023
Molecular Histopathology for Establishing Diagnostic Method and Clinical Therapy for Ovarian Carcinoma
By Takuma Hayashi et al. Journal of Clinical Medicine Research, Volume 15, Number 2, 2023.
Ovarian carcinoma (OC) is considered the deadliest gynecological malignancy. It is typically diagnosed in the advanced stages of the disease, with metastatic sites widely disseminated within the abdominal cavity. OC treatment is challenging due to the high rate of disease recurrence, which is further complicated by acquired chemoresistance caused by the reversion of the pathological variant. Read More....
• Jan 23, 2023
A Presentation of Synchronous Ovarian and Endometrial Endometrioid Adenocarcinoma From a Case of Suspected Ruptured Ectopic Pregnancy
By Siak Ming Goh et al. Journal of Medical Cases, Volume 14, Number 1, Jan 2023.
A 32-year-old woman of child-bearing age who initially underwent surgical laparoscopy for suspected ruptured ectopic pregnancy with elevated serum β-human chorionic gonadotropin (hCG) levels was unexpectedly found to have histologically diagnosed synchronous ovarian and endometrial endometrioid adenocarcinoma. Read More....
• Jan 2, 2023
Glycine Decarboxylase Suppresses the Renal Cell Carcinoma Growth and Regulates Its Gene Expressions and Functions
By Ye Da Chen et al. World Journal of Oncology, Volume 13, Number 6, Dec 2022.
Glycine decarboxylase (GLDC), a key metabolic enzyme, participates in the regulation of the glycine metabolic pathway. Differential expression of GLDC is linked to the malignant growth of renal cell carcinoma (RCC) and may regulate tumor progression through other genes. Read More....
• Dec 19, 2022
Barriers to Hepatitis C Virus Care and How Federally Qualified Health Centers Can Improve Patient Access to Treatment
By David Lam et al. Gastroenterology Research, Vol. 15, No. 6, Dec 2022
Despite the availability of direct-acting antiviral agents (DAAs) for hepatitis C virus (HCV) treatment, disparities in HCV care and treatment persist for underserved populations due to demographic-based and insurance-based barriers. Read More....
